ConductScience.org, home

Paper17517852

Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.

Marchand B and 7 others. Antimicrob Agents Chemother, 2007. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir. Papers, record 17517852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517852

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2018-11-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marchand BBruno
2White KLKirsten L
3Ly JKJohn K
4Margot NANicolas A
5Wang RRuth
6McDermott MMartin
7Miller MDMichael D
8Götte MMatthias

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenineMajor topic
Anti-HIV AgentsMajor topic
HIV Reverse TranscriptaseMajor topic
HIV-1Major topic
OrganophosphonatesMajor topic
Reverse Transcriptase InhibitorsMajor topic
Adenosine Triphosphate
Base Sequence
Drug Resistance, Viral
Humans
Kinetics
Microbial Sensitivity Tests
Molecular Sequence Data
Tenofovir
Zidovudine

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112610164
Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.
J Virol2003https://conductscience.org/library/papers/12610164PubMed
212069972ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12069972PubMed
312873144Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis.Biochemistry2003https://conductscience.org/library/papers/12873144PubMed
412819205Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance.J Biol Chem2003https://conductscience.org/library/papers/12819205PubMed
514976601Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.J Infect Dis2004https://conductscience.org/library/papers/14976601PubMed
614982794
Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14982794PubMed
715107837Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.Nat Struct Mol Biol2004https://conductscience.org/library/papers/15107837PubMed
815183347Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides.Int J Biochem Cell Biol2004https://conductscience.org/library/papers/15183347PubMed
915331732Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.J Virol2004https://conductscience.org/library/papers/15331732PubMed
1015482234Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance.Expert Rev Anti Infect Ther2004https://conductscience.org/library/papers/15482234PubMed
1115308646Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase.J Biol Chem2004https://conductscience.org/library/papers/15308646PubMed
124592524Analysis of nucleotide pools in animal cells.Methods Cell Biol1973https://conductscience.org/library/papers/4592524PubMed
132479983Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).Science1989https://conductscience.org/library/papers/2479983PubMed
141688798Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography.Eur J Biochem1990https://conductscience.org/library/papers/1688798PubMed
151705039Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1705039PubMed
161851154
5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives.
J Biol Chem1991https://conductscience.org/library/papers/1851154PubMed
171281479Mechanism and fidelity of HIV reverse transcriptase.J Biol Chem1992https://conductscience.org/library/papers/1281479PubMed
187692440Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7692440PubMed
197963708Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy.J Infect Dis1994https://conductscience.org/library/papers/7963708PubMed
207877593Physiological concentrations of purines and pyrimidines.Mol Cell Biochem1994https://conductscience.org/library/papers/7877593PubMed

See all 44 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42282742Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance Mutations.bioRxiv2026https://conductscience.org/library/papers/42282742PubMed
25341668Current perspectives on HIV-1 antiretroviral drug resistance.Viruses2014https://conductscience.org/library/papers/25341668PubMed
24102161Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus.J Med Chem2013https://conductscience.org/library/papers/24102161PubMed
23744599Recent findings on the mechanisms involved in tenofovir resistance.Antivir Chem Chemother2014https://conductscience.org/library/papers/23744599PubMed
23598281Formation of a quaternary complex of HIV-1 reverse transcriptase with a nucleotide-competing inhibitor and its ATP enhancer.J Biol Chem2013https://conductscience.org/library/papers/23598281PubMed
22664235Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract.Antiviral Res2012https://conductscience.org/library/papers/22664235PubMed
21994615Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.Viruses2010https://conductscience.org/library/papers/21994615PubMed
20733040Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20733040PubMed
20376302Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.Viruses2010https://conductscience.org/library/papers/20376302PubMed
20111609Allosteric regulation of HIV-1 reverse transcriptase by ATP for nucleotide selection.PLoS One2010https://conductscience.org/library/papers/20111609PubMed
19837673Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.J Biol Chem2009https://conductscience.org/library/papers/19837673PubMed
19665597Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.Biochim Biophys Acta2010https://conductscience.org/library/papers/19665597PubMed
19509419Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.J Biol Chem2009https://conductscience.org/library/papers/19509419PubMed
19439089The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.Retrovirology2009https://conductscience.org/library/papers/19439089PubMed
19210791Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.Retrovirology2009https://conductscience.org/library/papers/19210791PubMed
19022262Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.J Mol Biol2009https://conductscience.org/library/papers/19022262PubMed
18940786Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.J Biol Chem2008https://conductscience.org/library/papers/18940786PubMed
18547911Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.J Biol Chem2008https://conductscience.org/library/papers/18547911PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17517852

GET https://conductscience.org/api/papers/v1/17517852/references?page=2